Navigation Links
Pi2 Solutions Releases the Latest Version of its Product Literature Database System for the Biopharmaceutical Industry
Date:3/1/2010

LONDON, March 1, 2010 /PRNewswire/ -- Pi2 Solutions announces the all-new 2010 version of their world-leading Product Literature Database System. This versatile application builds on the success of the 2003 version in use in biopharmaceutical companies around the globe.

In addition to the well-appreciated Guided, Advanced, Author and Thesaurus search interfaces, the new version introduces a number of unique features to aid users of product related information:

    - Customisable Homepages: client administrators can set up multiple
      homepages so users in different pharma regions or therapeutic
      categories can use quick links to access specifically relevant content.
      Users can also configure a personal homepage using drag & drop

    - Variable user rights: different user groups can have restricted views
      on content

    - Current awareness: clickable email alerts for individuals or groups,
      daily, weekly, etc

    - Multiple indexes per article, each index specific to one drug allowing
      pinpoint association of, for example, AE or dosage information, with a
      specific drug

    - Links to full-article versions, according to subscriptions, and to
      various "Related Resources" that cite the literature, such as medical
      letters, monographs and much more

    - Study-specific indexing so that all publications from a given study can
      be quickly recognised and the resulting documentation readily
      downloaded

    - Ability to effortlessly download a Related Resource, its relevant
      bibliographic records and all associated full-articles and other PDFs

    - Complete intra-operability with Pi2's pipeline of downstream workflow
      tools, eg. Pi2's forthcoming software for handling submissions
      reference requests, creating and managing medical letters, the Pi2 KOL
      Db and Pi2 TrialWatch.

    - A new "Copy link" feature which enables pinpoint linking into a
      client's PLD from other client systems and documents.

    - Enhanced custom thesaurus handling capabilities

    - High performance and scalability to >1 million records

The roll-out of the Pi2 2010 PLD version to current clients will be completed in Q2 and new clients will automatically get the upgraded system. Demonstrations to prospective clients will feature the new system together with compatible Pi2 pipeline applications to assist users in their day to day workflow.

Pi2 Product Literature Database (PLD) Systems and Downstream Workflow Applications

Pi2 PLD systems track journal and conference articles that mention a client's drugs and, optionally, those of their competitors. Database records link to the full text articles, to various Related Resources that cite the literature and integrate with a variety of client end-user systems. They typically drive efficiency in an organisation, have a very low ownership cost and generally save a client company many times what they would spend on acquiring a Pi2 PLD. Pi2 PLD systems are widely regarded as being unrivalled in terms of functionality, ease of use and low burden of ownership. Pi2's "Downstream Workflow Applications" will increasingly enable end-users to create and manage their medical letters, create publications planning reports, organise KOLs, as well as tracking clinical trials and medical conferences. Seamless linking between the various Pi2 applications and integration with client internal systems ensure efficiency, greater workflow effectiveness and ease of working.

About Pi2 Solutions Ltd

Pi2 Solutions Ltd is a privately owned London-based company specialising in Product Literature Database (PLD) systems for the biopharmaceutical industry and "Downstream Workflow Applications" for key user groups in functions such as Medical Affairs, Marketing, Drug Safety, Publications Planning, Competitive Intelligence.

Established in 2002, Pi2 has an enviable portfolio of global biopharmaceutical clients from the very largest pharma companies to small emerging biotechs. The strategic aim of Pi2 is to continue to develop solutions for solving the workflow challenges of users of drug-related literature in departments such as libraries/knowledge centres, medical information, medical affairs, publications planning and communications teams, marketing and product strategy, competitive intelligence, drug safety/ pharmacovigilance and others.

For More Information Contact:

info@pi2solutions.com

SOURCE Pi2 Solutions Ltd

Back to top
'/>"/>
SOURCE Pi2 Solutions Ltd
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Tourtellotte Solutions Blazes Trail with New Release of Clinical Trial Supply Chain Simulator
2. Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.
3. Facet Solutions Enjoys Continued Clinical Success With the Anatomic Facet Replacement System (AFRS(TM))
4. Facet Solutions AFRS(TM) Demonstrates Biomechanical Advantages Over Dynamic Stabilization in Independent Testing
5. Siemens Medical Solutions Diagnostics Inks Agreement with KreLo Medical Diagnostics to Expand Thyroid Immunoassay Menu
6. DATATRAK(TM) Takes Clinical Trial Solutions to the Next Level With the Release of 5.0
7. EndoGastric Solutions(TM) Announces Results of EsophyX(TM) Multi-Center GERD Study
8. Elektas New Line of Stereotactic Treatment Solutions is Redefining Excellence in Stereotaxy, a Case at a Time
9. Aon eSolutions Launches Clinical Trials Module
10. MedNet Solutions to Sponsor and Exhibit at the 2008 Advanced Medical Technology Association Conference in Washington, D.C.
11. Facet Solutions Announces Completion of 6 Month Follow-Up in US Pilot Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016  In a startling report released today, National Safety ... lacking a comprehensive, proven plan to eliminate prescription opioid overdoses. ... how states are tackling the worst drug crisis in recorded U.S. ... Kentucky , New Mexico , ... Of the 28 failing states, three – Michigan ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... , June 23, 2016 , ... on Thursday, July 7, 2016 , , , , LOCATION: ... , , , , EXPERT PANELISTS:  , , , ... Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and ... The global pharmaceutical industry is witnessing an exceptional era. ...
Breaking Medicine Technology:
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/25/2016)... ... , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department ... in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at ... Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
Breaking Medicine News(10 mins):